Skip to content. | Skip to navigation

Personal tools

This is SunRain Plone Theme

Navigation

banner2
banner7
banner6
banner10
banner13
banner12
banner18
banner17
banner11
banner14
banner9
banner5
banner15
banner16
banner1
banner8
banner0
banner3
banner4
You are here: Home / Staff / Agreements with industrial partners

Agreements with industrial partners

 The IGB-ABT strongly believes that a close collaboration between academia and the industrial sector represents a key element to carry out innovative research. Indeed, several groups closely interact with SMEs and big pharmaceutical companies: GW Pharmaceuticals, Genzyme-Sanofi, Sigma-Tau, Bio-Ker, Multimedica Group, Diatech Pharmacogenetics and Selyno. The ultimate goal is to either 1) develop novel drugs, 2) identify novel biomarkers, or 3) better characterize human rare diseases. In addition, IGB-ABT has 3 active patents and 3 novel patent applications.

  Bioker s.r.l. phone/fax: +39 081 6132 412

  • Giancarlo Tonon
  • Silvia Scaramuzza
  • Rodolfo Schrepfer
  • Fabio Selis

 

IRBM  phone/fax: +39 081 6132 463

  • Francesca Varrone
  • Giacomo Metta
  • Luca Giorgio Wanderlingh